Evidence map›Paper›PMID 42350674›Full record

ArticleThe EMBO journal2026

Cellular assembly and functional resilience of the mammalian RNA exosome.

Tsimafei Navalayeu, Nikolaus Beer, Monika Bebjaková, Robert W Kalis, Ulrich Hohmann, Karel Stejskal, Gabriela Krššáková, Nina Fasching, Veronika A Herzog, Niko Popitsch and 4 more

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tsimafei NavalayeuMax Perutz Labs, Vienna BioCenter (VBC), Dr.-Bohr-Gasse 9, A-1030, Vienna, Austria.
Nikolaus BeerMax Perutz Labs, Vienna BioCenter (VBC), Dr.-Bohr-Gasse 9, A-1030, Vienna, Austria.ORCID http://orcid.org/0009-0009-2524-0303
Monika BebjakováMax Perutz Labs, Vienna BioCenter (VBC), Dr.-Bohr-Gasse 9, A-1030, Vienna, Austria.
Robert W KalisVienna BioCenter PhD Program, a Doctoral School of the University of Vienna and the Medical University of Vienna, A-1030, Vienna, Austria.
Ulrich HohmannResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), 1030, Vienna, Austria.ORCID http://orcid.org/0000-0003-2124-1439
Karel StejskalInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), A-1030, Vienna, Austria.ORCID http://orcid.org/0009-0005-6430-4550
Gabriela KrššákováInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), A-1030, Vienna, Austria.
Nina FaschingInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), A-1030, Vienna, Austria.
Veronika A HerzogInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), A-1030, Vienna, Austria.
Niko PopitschMax Perutz Labs, Vienna BioCenter (VBC), Dr.-Bohr-Gasse 9, A-1030, Vienna, Austria.ORCID http://orcid.org/0000-0002-2318-2391
Elisabeth RoitingerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), A-1030, Vienna, Austria.ORCID http://orcid.org/0000-0002-3405-7801
Clemens PlaschkaResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), 1030, Vienna, Austria.ORCID http://orcid.org/0000-0002-6020-9514
Johannes ZuberResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), 1030, Vienna, Austria.ORCID http://orcid.org/0000-0001-8810-6835
Stefan L AmeresMax Perutz Labs, Vienna BioCenter (VBC), Dr.-Bohr-Gasse 9, A-1030, Vienna, Austria. stefan.ameres@maxperutzlabs.ac.at.ORCID http://orcid.org/0000-0002-8248-3098

Funding

Austrian Science Fund (FWF) 10.55776/DOC177Austrian Science Fund (FWF) 10.55776/F80Boehringer Ingelheim Fonds (BIF) PhD FellowshipEC | European Research Council (ERC) CoG-866166Vienna Science and Technology Fund (WWTF) LS23-053
6 · The paper itself

Abstract

Most eukaryotic proteins assemble into multisubunit complexes that coordinate essential cellular functions, yet the principles governing their assembly and proteostatic control remain largely undefined. Here, we systematically dissect the cellular assembly and functional organization of the RNA exosome, an essential ribonucleolytic complex, using an inducible dual-guide CRISPR/Cas9 system in mouse embryonic stem cells. We reveal a sequential assembly pathway where Exosc2, Exosc4, and Exosc7 initiate complex formation, facilitating the incorporation of barrel and cap subunits in a defined hierarchy. Unlike other structural subunits, the terminally incorporated cap subunit Exosc1 is dispensable for cell viability, revealing a modular, functionally resilient architecture. We demonstrate that orphan subunits are selectively degraded via the ubiquitin-proteasome system, enforcing stringent quality control over RNA exosome biogenesis. These findings define an assembly logic of of the mammalian exosome and uncover previously unrecognized plasticity in the composition and function of this essential ribonucleolytic complex.

Indexed as

Exosome Multienzyme Ribonuclease ComplexExosomesMouse Embryonic Stem CellsAnimalsCRISPR-Cas SystemsMiceProteasome Endopeptidase ComplexRNARNA-Binding ProteinsExosome Multienzyme Ribonuclease ComplexProteasome Endopeptidase ComplexRNARNA-Binding Proteins

Identifiers

PMID42350674
PMCPMC13434269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.